Dynamics of Retinal Vessel Loss After Acute Optic Neuritis in Patients With Relapsing Multiple Sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 23, 2021
- Accepted in final form January 3, 2022
- First Published March 17, 2022.
Author Disclosures
- Lilian Aly, MD (lilian.aly{at}tum.de),
- Christina Noll (christina.noll{at}tum.de),
- Rebecca Wicklein, MD (rebecca.wicklein{at}tum.de),
- Elisabeth Wolf (e.wolf.1997{at}web.de),
- Eva Feodora Romahn (feodora.romahn{at}tum.de),
- Josphine Wauschkuhn (josephine.wauschkuhn{at}gmail.com),
- Sami Hosari, MD (sami.hosari{at}uk-erlangen.de),
- Christian Mardin, MD (christian.mardin{at}uk-erlangen.de),
- Achim Berthele, MD (achim.berthele{at}tum.de),
- Bernhard Hemmer, MD (hemmer{at}tum.de),
- Thomas Korn, MD (thomas.korn{at}tum.de) and
- Benjamin Knier, MD
- Lilian Aly, MD (lilian.aly{at}tum.de),
NONE
NONE
Novartis Funding for travel to the MS Research Day Berlin, 2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christina Noll (christina.noll{at}tum.de),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Gemeinnützige Hertie Foundation (medMS program)
NONE
NONE
NONE
NONE
NONE
NONE
- Rebecca Wicklein, MD (rebecca.wicklein{at}tum.de),
NONE
NONE
Travel Grant ECTRIMS 2021 for Poster presentation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research fellowship of Klinikum rechts der Isar, Technische Universität Munich
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elisabeth Wolf (e.wolf.1997{at}web.de),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eva Feodora Romahn (feodora.romahn{at}tum.de),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Josphine Wauschkuhn (josephine.wauschkuhn{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sami Hosari, MD (sami.hosari{at}uk-erlangen.de),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian Mardin, MD (christian.mardin{at}uk-erlangen.de),
NONE
NONE
Heidelberg Engineering, Heidelberg, Germany
Klinische Monatsblätter Augenheilkunde 2020-2022
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Achim Berthele, MD (achim.berthele{at}tum.de),
(1) Alexion Pharma (2) Biogen (3) Celgene (4) Roche Pharma (5) Hexal/Novartis
NONE
(1) Alexion Pharma, funding for travel and speaker honoraria (2) Bayer Healthcare, speaker honoraria (3) Biogen, speaker honoraria (4) Roche Pharma, funding for travel and speaker honoraria.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Bernhard Hemmer, MD (hemmer{at}tum.de),
Advisory Boards for Novartis, he has served as DSMB member for AllergyCare, TG Therapeutics and Polpharma Biologics
Me or my institution have received speaker honoraria from Desitin
NONE
Editorial board member of Experimental Neurology and Multiple sclerosis Journal
I hold part of two patents; one for the detection of antibodies and T cells against KIR4.1 in a subpopulati on of MS patients and one for genetic determinants of neutralizing antibodies to interferon beta
NONE
NONE
NONE
NONE
NONE
NONE
Regeneron - not related, Research grants from the German research foundation, the Bundesministerium für Bildung und Forschung and the European Community
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Korn, MD (thomas.korn{at}tum.de) and
(1) Sanofi Genzyme (2) Novartis (3) Roche (4) Janssen
NONE
(1) Novartis (2) Alexion
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Deutsche Forschungsgemeinschaft (DFG): KO2964/2-1, KO2964/3-1, KO2964/4-1, KO2964/5-1, SFB1054- B06, TRR128-A07, TRR128-A12, TRR274-A01, Synergy EXC2145. (2) European Research Council (ERC): CoG647215.
NONE
(1) Gemeinnützige Hertie-Stiftung (Hertie Foundation).
NONE
NONE
NONE
NONE
NONE
NONE
- Benjamin Knier, MD
NONE
NONE
(1) Bayer, Travel Compensation (2) Merck Serono, Travel Compensation (3) ECTRIMS (non-profit), travel grant (4) Neurowind e.V. (non-profit), travel grant (5) Novartis, Travel Compensation
(1) Frontiers in Neurology, Review Editor, 2020 (2) Frontiers in Immunology, Review Editor, 2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Novartis, research grant (2) Novartis, research award "Oppenheim research fund"
(1) Kompetenznetz Multiple Sklerose (non-profit) of the Bundesministerium für Bildung und Forschung, seed research grant, 2014
(1) Kommission für Klinische Foschung (KKF), intramural research grant from the Technical University of Munich
(1) Else Kröner Fresenius-Stiftung, Else Kröner Exzellenzstipendium 2019
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (L.A., C.N., R.W., E.W., E.F.R., J.W., A.B., B.H., T.K., B.K.), Klinikum rechts der Isar, Institute for Experimental Neuroimmunology (L.A., T.K., B.K.), Technical University of Munich; Department of Ophthalmology (S.H., C.M.), University Hospital of Erlangen-Nuremberg; and Munich Cluster for Systems Neurology (SyNergy) (B.H., T.K.), Germany.
- Correspondence
Dr. Knier benjamin.knier{at}tum.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.